When 1+1=3 is Good Math for Brands
With an ever evolving healthcare landscape, brands are moving quickly to remain ahead of the competition. ghg has done the math, and a franchise approach to pharmaceutical marketing within a therapeutic category is optimal for establishing and growing category leadership in the market.
President and CEO Lynn O'Connor Vos provides essential insights in her guest commentary piece in PM360's September issue. Download the article to learn:
- How to drive category leadership
- The importance of delivering a real value story
- Why the whole is greater than the sum of its parts
Click here to view the entire article and learn how to effectively build brand success.
Let Us Assess Your Digital Footprint
Driving Brand Opportunity Through Social Media Advocacy
With social networks playing an increasingly important role in the healthcare decision-making process, pharmaceutical companies are starting to join the conversation. So how can pharmaceutical marketers assess the impact of their social media activities? The answer lies in a new metric—social media advocacy.
True brand opportunity lies in building advocacy. And advocacy goes beyond traditional measures of “Likes” and “Followers” to evaluate impact. Strong advocacy strategies identify the best social experiences for engaging target audiences and motivating them to take action. To create the most productive digital strategies, companies should perform a full diagnostic assessment of all their digital channels.
Learn how in ghg’s article on social media advocacy.